NuVasive reported a second quarter revenue increase of 35.2 percent over last year's second quarter, and a 9.6 percent increase over the first quarter of 2010 due in part to adopting XLIF technology, according to a NuVasive news report.
Total revenue reached $119.6 million for the quarter, and gross profit was $98.6 million, up 82.4 percent from the second quarter of last year. The total GAAP operating expenses for the second quarter were $90.3 million as compared to $86.7 million for last year's second quarter and $86.7 million for the first quarter 2010.
Cash, cash equivalents and short and long-term marketable securities were at $213.2 million on June 30, 2010, while operation cash flow was $16.3 million for the second quarter of 2010.
Read the NuVasive report on the 2010 2Q FY results.
Read other coverage on NuVasive:
- Two Insurers Reverse Policies to Cover XLIF Procedures
- Vail-Summit Spine Surgeon First to Use MAS-TLIF for Minimally Invasive Spine Fusion
- Spine Surgery Company NuVasive Reports 42 Percent Sales Increase
Total revenue reached $119.6 million for the quarter, and gross profit was $98.6 million, up 82.4 percent from the second quarter of last year. The total GAAP operating expenses for the second quarter were $90.3 million as compared to $86.7 million for last year's second quarter and $86.7 million for the first quarter 2010.
Cash, cash equivalents and short and long-term marketable securities were at $213.2 million on June 30, 2010, while operation cash flow was $16.3 million for the second quarter of 2010.
Read the NuVasive report on the 2010 2Q FY results.
Read other coverage on NuVasive:
- Two Insurers Reverse Policies to Cover XLIF Procedures
- Vail-Summit Spine Surgeon First to Use MAS-TLIF for Minimally Invasive Spine Fusion
- Spine Surgery Company NuVasive Reports 42 Percent Sales Increase